Michael F. Mahoney

2018

In 2018, Michael F. Mahoney earned a total compensation of $14M as Chairman of the Board, President and Chief Executive Officer at Boston Scientific, a 7% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$311,932
Non-Equity Incentive Plan$2,128,770
Option Awards$2,499,993
Salary$1,234,630
Stock Awards$7,643,884
Other$151,692
Total$13,970,901

Mahoney received $7.6M in stock awards, accounting for 55% of the total pay in 2018.

Mahoney also received $311.9K of change in pension value and nonqualified deferred compensation earnings, $2.1M in non-equity incentive plan, $2.5M in option awards, $1.2M in salary and $151.7K in other compensation.

Rankings

In 2018, Michael F. Mahoney's compensation ranked 368th out of 14,244 executives tracked by ExecPay. In other words, Mahoney earned more than 97.4% of executives.

ClassificationRankingPercentile
All
368
out of 14,244
97th
Division
Manufacturing
124
out of 5,758
98th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
16
out of 849
98th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
7
out of 547
99th
Industry
Surgical and Medical Instruments and Apparatus
2
out of 348
99th

Pay ratio

Michael F. Mahoney's Pay$13,970,901
Median Employee's Pay$62,447
Pay Ratio

224

to 1

In 2018, the annual total compensation of Michael F. Mahoney was $13,970,901.

The annual total compensation of the median employee at Boston Scientific was $62,447.

The ratio of Michael F. Mahoney's pay to the pay of median employee was therefore 224 to one.

Source: SEC filing on March 27, 2019.

Mahoney's colleagues

We found four more compensation records of executives who worked with Michael F. Mahoney at Boston Scientific in 2018.

2018

Joseph Fitzgerald

Boston Scientific

Executive Vice President and President, Rhythm Management

2018

Daniel Brennan

Boston Scientific

Chief Financial Officer

2018

Kevin Ballinger

Boston Scientific

Executive Vice President and President, Interventional Cardiology

2018

David Pierce

Boston Scientific

Executive Vice President and President, MedSurg

News

You may also like